Women's Awareness and Perceived Importance of the Harms and Benefits of Mammography Screening: Results From a 2016 National Survey

doi:10.1001/jamainternmed.2017.2247

. 2017 Sep 1;177(9):1381-1382.

doi: 10.1001/jamainternmed.2017.2247.

Women's Awareness and Perceived Importance of the Harms and Benefits of Mammography Screening: Results From a 2016 National Survey

Jiani Yu¹, Rebekah H Nagler², Erika Franklin Fowler³, Karla Kerlikowske^{4

5}, Sarah E Gollust¹

Affiliations

¹ Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis.
² School of Journalism and Mass Communication, University of Minnesota, Minneapolis.
³ Government Department, Wesleyan University, Middletown, Connecticut.
⁴ Department of Medicine, University of California-San Francisco, San Francisco.
⁵ Department of Epidemiology/Biostatistics, University of California-San Francisco, San Francisco.

PMID: 28654987
PMCID: PMC5818835
DOI: 10.1001/jamainternmed.2017.2247

Women's Awareness and Perceived Importance of the Harms and Benefits of Mammography Screening: Results From a 2016 National Survey

Jiani Yu et al. JAMA Intern Med. 2017.

. 2017 Sep 1;177(9):1381-1382.

doi: 10.1001/jamainternmed.2017.2247.

Authors

Jiani Yu¹, Rebekah H Nagler², Erika Franklin Fowler³, Karla Kerlikowske^{4

5}, Sarah E Gollust¹

Affiliations

¹ Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis.
² School of Journalism and Mass Communication, University of Minnesota, Minneapolis.
³ Government Department, Wesleyan University, Middletown, Connecticut.
⁴ Department of Medicine, University of California-San Francisco, San Francisco.
⁵ Department of Epidemiology/Biostatistics, University of California-San Francisco, San Francisco.

PMID: 28654987
PMCID: PMC5818835
DOI: 10.1001/jamainternmed.2017.2247

Abstract

This survey study examines how women in the general US population perceive the benefits and harms of mammography screening.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Cited by

Cancer overdiagnosis: a challenge in the era of screening.
Dunn BK, Woloshin S, Xie H, Kramer BS. Dunn BK, et al. J Natl Cancer Cent. 2022 Dec;2(4):235-242. doi: 10.1016/j.jncc.2022.08.005. Epub 2022 Aug 21. J Natl Cancer Cent. 2022. PMID: 36568283 Free PMC article.
Quality of Informed Consent in Mammography Screening-The Polish Experience.
Zagaja A, Bogusz R, Sak J, Wiechetek M, Pawlikowski J. Zagaja A, et al. Int J Environ Res Public Health. 2022 May 31;19(11):6735. doi: 10.3390/ijerph19116735. Int J Environ Res Public Health. 2022. PMID: 35682316 Free PMC article.
À l’encontre du statu quo en matière de dépistage: Appel à l’action pour améliorer l’enseignement des soins de santé préventifs.
Antao V, Grad R, Thériault G, Dickinson JA, Szafran O, Singh H, Rezkallah R, Waugh E, Bell NR. Antao V, et al. Can Fam Physician. 2022 May;68(5):e140-e145. doi: 10.46747/cfp.6805e140. Can Fam Physician. 2022. PMID: 35552220 Free PMC article. French. No abstract available.
Going against the status quo in screening: Call to action to improve teaching in preventive health care.
Antao V, Grad R, Thériault G, Dickinson JA, Szafran O, Singh H, Rezkallah R, Waugh E, Bell NR. Antao V, et al. Can Fam Physician. 2022 May;68(5):340-344. doi: 10.46747/cfp.6805340. Can Fam Physician. 2022. PMID: 35552217 Free PMC article. No abstract available.
Perceptions of Conflicting Breast Cancer Screening Recommendations Among Racially/Ethnically Diverse Women: a Multimethod Study.
Housten AJ, Hoover DS, Britton M, Bevers TB, Street RL, McNeill LH, Strong LL, Hersch J, McCaffery K, Volk RJ. Housten AJ, et al. J Gen Intern Med. 2022 Apr;37(5):1145-1154. doi: 10.1007/s11606-021-07336-w. Epub 2022 Jan 11. J Gen Intern Med. 2022. PMID: 35015260 Free PMC article.

See all "Cited by" articles

References

1. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311(13):1327-1335. - PubMed
1. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-78. - PubMed
1. Hoffmann TC, Del Mar C. Patients’ expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Intern Med. 2015;175(2):274-286. - PubMed
1. Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG. US women’s attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ. 2000;320(7250):1635-1640. - PMC - PubMed
1. Wegwarth O, Gigerenzer G. Less is More: overdiagnosis and overtreatment: evaluation of what physicians tell their patients about screening harms. JAMA Intern Med. 2013;173(22):2086-2087. - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

K12 HD055887/HD/NICHD NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311(13):1327-1335. - PubMed

[2] Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311(13):1327-1335. - PubMed

[3] Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-78. - PubMed

[4] Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-78. - PubMed

[5] Hoffmann TC, Del Mar C. Patients’ expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Intern Med. 2015;175(2):274-286. - PubMed

[6] Hoffmann TC, Del Mar C. Patients’ expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Intern Med. 2015;175(2):274-286. - PubMed

[7] Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG. US women’s attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ. 2000;320(7250):1635-1640. - PMC - PubMed

[8] Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG. US women’s attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ. 2000;320(7250):1635-1640. - PMC - PubMed

[9] Wegwarth O, Gigerenzer G. Less is More: overdiagnosis and overtreatment: evaluation of what physicians tell their patients about screening harms. JAMA Intern Med. 2013;173(22):2086-2087. - PubMed

[10] Wegwarth O, Gigerenzer G. Less is More: overdiagnosis and overtreatment: evaluation of what physicians tell their patients about screening harms. JAMA Intern Med. 2013;173(22):2086-2087. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Women's Awareness and Perceived Importance of the Harms and Benefits of Mammography Screening: Results From a 2016 National Survey

Affiliations

Women's Awareness and Perceived Importance of the Harms and Benefits of Mammography Screening: Results From a 2016 National Survey

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical